Cargando…

Development of expression-based biomarkers of Dasatinib response in hematologic malignancies

Detalles Bibliográficos
Autores principales: Akre, Monica K., Mitra, Amit, Wang, Wen, Myers, Chad L., Van Ness, Brian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802564/
https://www.ncbi.nlm.nih.gov/pubmed/29242603
http://dx.doi.org/10.1038/s41408-017-0013-z
_version_ 1783298544960012288
author Akre, Monica K.
Mitra, Amit
Wang, Wen
Myers, Chad L.
Van Ness, Brian
author_facet Akre, Monica K.
Mitra, Amit
Wang, Wen
Myers, Chad L.
Van Ness, Brian
author_sort Akre, Monica K.
collection PubMed
description
format Online
Article
Text
id pubmed-5802564
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-58025642018-02-08 Development of expression-based biomarkers of Dasatinib response in hematologic malignancies Akre, Monica K. Mitra, Amit Wang, Wen Myers, Chad L. Van Ness, Brian Blood Cancer J Correspondence Nature Publishing Group UK 2017-12-15 /pmc/articles/PMC5802564/ /pubmed/29242603 http://dx.doi.org/10.1038/s41408-017-0013-z Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Akre, Monica K.
Mitra, Amit
Wang, Wen
Myers, Chad L.
Van Ness, Brian
Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title_full Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title_fullStr Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title_full_unstemmed Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title_short Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
title_sort development of expression-based biomarkers of dasatinib response in hematologic malignancies
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5802564/
https://www.ncbi.nlm.nih.gov/pubmed/29242603
http://dx.doi.org/10.1038/s41408-017-0013-z
work_keys_str_mv AT akremonicak developmentofexpressionbasedbiomarkersofdasatinibresponseinhematologicmalignancies
AT mitraamit developmentofexpressionbasedbiomarkersofdasatinibresponseinhematologicmalignancies
AT wangwen developmentofexpressionbasedbiomarkersofdasatinibresponseinhematologicmalignancies
AT myerschadl developmentofexpressionbasedbiomarkersofdasatinibresponseinhematologicmalignancies
AT vannessbrian developmentofexpressionbasedbiomarkersofdasatinibresponseinhematologicmalignancies